Search Within

Lisa De Angelis

  1. "Multidisciplinary Brain Metastasis Program"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (10)
Groups
  1. Multidisciplinary Brain Metastasis Program (20)
  2. Tow Center for Developmental Oncology (TCDO) (20)
  3. Neuroradiology Service (17)
  4. Radiology, Department of (17)
  5. GSK Faculty (16)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (14)

More Groups

People
  1. Kathryn Beal (19)
  2. Antonio Omuro (12)
  3. Philip Gutin (12)
  4. Timothy Chan (12)
  5. Thomas Kaley (11)
  6. Robert Young (10)

More People

Years
  1. 2024 (1)
  2. 2019 (3)
  3. 2018 (4)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Neuro-Oncology (4)
  3. Clinical Cancer Research (3)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Cancer (1)
  6. Journal of Clinical Endocrinology and Metabolism (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Oxford University Press (5)
  3. American Association for Cancer Research (3)
  4. Elsevier Inc. (2)
  5. Endocrine Society (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and clinical effects of notch inhibition in glioma patients: A phase 0/I trial
    Journal Article

    Xu, R.; Shimizu, F.; Hovinga, K.; Beal, K.; Karimi, S.; Droms, L.; Peck, K. K.; Gutin, P.; Iorgulescu, J. B.; Kaley, T.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Thomas, A. A.; Beal, K.; McNeill, K. A.; Kaley, T. J.; Deangelis, L. M.; Mellinghoff, I. K.; Diamond, E. L.; Chan, T. A. T.; Young, R. J.; Perez, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Ro4929097 in combination with radiotherapy and temozolomide for newly diagnosed malignant glioma (MG): A pharmacokinetic (Pk) and pharmacodynamic (Pd) study
    Meeting Abstract

    Omuro, A.; Beal, K.; Ivy, P.; Gutin, P.; Wu, N.; Kaley, T.; Karimi, S.; DeAngelis, L.; Pentsova, E.; Nolan, C.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
    Meeting Abstract

    Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ) and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Beal, K.; Omuro, A.; Karimi, S.; Correa, D.; Chan, T. A.; Deangelis, L. M.; Yamada, Y.; Abrey, L. E.; Gutin, P. H.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
    Journal Article

    Iwamoto, F. M.; Abrey, L. E.; Beal, K.; Gutin, P. H.; Rosenblum, M. K.; Reuter, V. E.; Deangelis, L. M.; Lassman, A. B.
    Neurology (2009)

    Fulltext@MSK | Save